{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:54:22Z","timestamp":1789095262779,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijantimicag.2016.09.017","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T09:17:34Z","timestamp":1477991854000},"page":"703-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity"],"prefix":"10.1016","volume":"48","author":[{"given":"Leandro S.","family":"Sangenito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"d'Avila-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta H.","family":"Branquinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/QCO.0b013e328354f179","article-title":"Chagas disease in the immunosuppressed host","volume":"25","author":"Bern","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0025","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jps.23010","article-title":"First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems","volume":"101","author":"Salomon","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"1","author":"Urbina","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole\u2014a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0040","article-title":"Fexinidazole: a potential new drug candidate for Chagas disease","volume":"11","author":"Bahia","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1590\/S0037-86822011000600021","article-title":"Co-infection Trypanosoma cruzi\/HIV: systematic review (1980\u20132010)","volume":"44","author":"Almeida","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0050","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1590\/0074-0276130565","article-title":"Chagas disease: control, elimination and eradication. Is it possible?","volume":"108","author":"Coura","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","article-title":"In silico repositioning of approved drugs for rare and neglected diseases","volume":"16","author":"Ekins","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0060","series-title":"Drug repositioning","first-page":"9","article-title":"Drug repositioning: the business case and current strategies to repurpose shelved candidates and marketed drugs","author":"Arrowsmith","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2016.09.017_bib0065","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.4081\/idr.2013.s1.e2","article-title":"Recent developments in HIV treatment and their dissemination in poor countries","volume":"5","author":"Ebrahim","year":"2013","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1874104501105010040","article-title":"HIV protease inhibitors: effect on the opportunistic protozoan parasites","volume":"5","author":"Alfonso","year":"2011","journal-title":"Open Med Chem J"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0075","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.2174\/0929867311320250007","article-title":"Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy","volume":"20","author":"Santos","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"Trudel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"Santos","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.exppara.2010.06.002","article-title":"Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp","volume":"126","author":"Valdivieso","year":"2010","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/jac\/dks410","article-title":"Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients","volume":"68","author":"Santos","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijantimicag.2016.06.024","article-title":"HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi","volume":"48","author":"Sangenito","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1550-7408.1982.tb04024.x","article-title":"Adhesion and interiorization of Trypanosoma cruzi in mammalian cells","volume":"29","author":"Andrews","year":"1982","journal-title":"J Protozool"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0115","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.bmc.2014.07.030","article-title":"2-Phenylaminonaphthoquinones and related compounds: synthesis, trypanocidal and cytotoxic activities","volume":"22","author":"Sieveking","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113957","article-title":"Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model","volume":"9","author":"Sangenito","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jinsphys.2006.10.006","article-title":"Exploring the role of insect host factors in the dynamics of Trypanosoma cruzi\u2013Rhodnius prolixus interactions","volume":"53","author":"Garcia","year":"2007","journal-title":"J Insect Physiol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0135","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.micinf.2012.09.003","article-title":"Virulence factors of Trypanosoma cruzi: who is who?","volume":"14","author":"Osorio","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1017\/S0031182014000407","article-title":"In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi","volume":"141","author":"Timm","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1099\/00222615-42-5-362","article-title":"Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis","volume":"42","author":"Ramadan","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.40.2.314","article-title":"Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia","volume":"40","author":"Edelstein","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0155","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.1073\/pnas.96.20.11015","article-title":"Cysteine protease inhibitors as chemotherapy: lessons from a parasite target","volume":"96","author":"Selzer","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/jmbi.1994.0137","article-title":"The crystal structure of cruzain: a therapeutic target for Chagas' disease","volume":"247","author":"McGrath","year":"1995","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0165","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570162043351129","article-title":"Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view","volume":"2","author":"Clevenbergh","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/rcm.3411","article-title":"Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography\/tandem mass spectrometry detection","volume":"22","author":"Estrela","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0180","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1567-5769(01)00090-X","article-title":"Nitric oxide in parasitic infections","volume":"1","author":"Brunet","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.intimp.2014.12.025","article-title":"Anti-HIV drugs, lopinavir\/ritonavir and atazanavir, modulate innate immune response triggered by Leishmania in macrophages: the role of NF-\u03baB and PPAR-\u03b3","volume":"24","author":"Alves","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijantimicag.2016.09.017_bib0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir Ther"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T22:27:49Z","timestamp":1657578469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916303132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0924857916303132"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.09.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and International Society of Chemotherapy.","name":"copyright","label":"Copyright"}]}}